UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 9, 2026
Exercise
Calculated transaction value
$1.12M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 8, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$497.97
Sep 8, 2026
Close before public filing
$497.97
Sep 8, 2026
Return since public filing
-0.17%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,500 shares @ $117.76
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000137
Filing cohort
Transactions in this filing
Showing 15 of 17
Trades
17
Issuers
1
Estimated value
$5.86M
Buys / sales
0 / 15
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR Current | Exercise | Sep 8, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $19.28K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $96.78K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $108.03K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $68.98K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $71.13K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $296.92K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $126.91K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $149.12K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $947.53K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $507.75K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $586.73K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $611.93K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $586.13K |
| United Therapeutics Corp UTHR | Sale | Sep 8, 2026 | $352.83K |